The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. [email protected]Joanne E. McKenzieSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaPatrick M. BossuytDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, NetherlandsIsabelle BoutronUniversité de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004, Paris, FranceTammy HoffmannInstitute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, AustraliaCynthia D. MulrowAnnals of Internal Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USALarissa ShamseerKnowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaJennifer TetzlaffElie A. AklClinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaSue BrennanSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaRoger ChouDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USAJulie GlanvilleYork Health Economics Consortium (YHEC Ltd), University of York, York, UKJeremy GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, CanadaAsbjørn HróbjartssonCentre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, JB Winsløwsvej 9b, 3rd Floor, 5000 Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, DenmarkManoj M. LaluDepartment of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, CanadaTianjing LiDepartment of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAElizabeth LoderDivision of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Head of Research, The BMJ, London, UKEvan Mayo‐WilsonDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USASteve McDonaldSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaLuke A. McGuinnessPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKLesley StewartCentre for Reviews and Dissemination, University of York, York, UKJames ThomasEPPI-Centre, UCL Social Research Institute, University College London, London, UKAndrea C. TriccoLi Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division of the Dalla Lana School of Public Health and the Institute of Health Management, Policy, and Evaluation, University of Toronto, Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaVivian WelchMethods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaPenny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDavid MoherCentre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada
2021en
ABI
Аннотация
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 7Использованных источников: 0